Dr. Giancarlo Agnelli discusses findings that prophylactic low-molecular weight heparin reduced thromboembolic events by half in a study of ambulatory cancer patients. Dr. J. Evan Sadler comments on the implications of this study. Jane MacNeil of Elsevier Global Medical News (EGMN) reports from the annual meeting of the American Society of Hematology.